TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

1,148

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2009

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

methotrexate

DRUG

prednisolone

DRUG

prednisone

DRUG

therapeutic hydrocortisone

DRUG

vincristine sulfate

Trial Locations (2)

F-94805

Institut Gustave Roussy, Villejuif

S10 2TH

Children's Hospital - Sheffield, Sheffield

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Societe Francaise Oncologie Pediatrique

OTHER

collaborator

Children's Cancer and Leukaemia Group

OTHER

lead

Children's Oncology Group

NETWORK

NCT00002757 - TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter